It is aimed at supporting and encouraging scientists focused on basic or translational research that advances medical progress in regenerative medicine and cell therapy. Established in 2017, the prize is awarded for outstanding research performed by the applicant and as a mutual endeavor to raise awareness for the field and its fundamental significance for our future.Entries can be made in the fields of regenerative medicine, cell therapy, gene therapy, immunotherapy as well as materials and tissue engineering.
The winner last year was Kole Roybal, Ph.D., Assistant Professor at University of California, who uses synthetic and chemical biology to engineer the immune cells therapies for cancer and autoimmunity of the future. His submission was called Refining cell therapy: Synthetic Notch receptors expand the therapeutic potential of engineered T cells.
Please submit a 1,000-word essay describing your research and its implications for the field as well as supporting documents. The work of the applicants will be assessed and evaluated by a panel drawn from the American Association for the Advancement of Science (AAAS) and its journals.